Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEO 43204 in moderate to severe acne
NCT02575950Phase 2Completed
- Sponsor
- LEO Pharma
- Start
- Jun 2016
- Primary completion
- Apr 2017
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ingenol disoxate in acne vulgaris, sponsored by LEO Pharma. Started Jun 2016; status: completed.
02
Drugs
ingenol disoxate
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02575950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02575950.